About: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1994 (uk) im April 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1994 (ast) scientific article published on 01 April 1994 (en)
publication date	wds:Q72344109-FDA3BE1A-3308-4837-8893-DBD286EF9035
publication date	1994-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72344109-2AFFEE1D-8429-4CE0-92E9-32F1DB89BDB2
language of work or name	English
rdfs:label	Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (en) Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (nl)
skos:prefLabel	Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (en) Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (nl)
name	Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (en) Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (nl)
title	wds:Q72344109-9298A211-0618-480D-A51F-BB01F7BF61EB
title	Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia (en)
page(s)	wds:Q72344109-343C4D36-90F2-4B95-9985-1B6D7D8B56A1
page(s)	1545-1556
instance of	wds:Q72344109-CE1D2FFB-CEFB-4E05-86C0-70CC9E2F61E4
instance of	scholarly article
main subject	wds:Q72344109-2789A206-7CCF-452F-A40A-81039AA643FA wds:Q72344109-B44919B6-2885-42B6-A4A1-84B1C0AA29FF wds:Q72344109-E6D2D18C-63EF-489E-80F6-2339C8A08875 wds:Q72344109-F00A59FD-6255-4FFD-B23B-87BC4D3BAC48
main subject	plasminogen thrombolysis unstable angina myocardial ischemia
PubMed ID	wds:Q72344109-4FE76243-837E-496E-A3B9-68D8DA54BB0B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8149520
PubMed ID	8149520
published in	wds:Q72344109-32737525-F507-4629-A796-321C57E8D909
published in	Circulation
issue	wds:Q72344109-62EFC541-7116-43E9-B7ED-C78E2A2697AF
volume	wds:Q72344109-E41983F7-EC38-43C0-B037-0F8FDE0E2B9A
issue	4
volume	89
DOI	wds:Q72344109-5AC7513E-D227-4744-AC8B-66D64B1DABB2
DOI	http://dx.doi.org/10.1161/01.CIR.89.4.1545
DOI	10.1161/01.CIR.89.4.1545
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72344109
is cites work of	Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 Using a Systemwide Care Path to Enhance Compliance with Guidelines for Acute Myocardial Infarction Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischemic coronary syndromes. Platelet Glycoprotein IIb-IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Ang Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era. Identifying Patient Risk: The Basis for Rational Discharge Planning After Acute Myocardial Infarction Systematic adjudication of myocardial infarction end-points in an international clinical trial Refractory angina pectoris: mechanism and therapeutic options. Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: applicability to the practice of medicine in the United States Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study Optimizing the Treatment of Unstable Angina. Clinical predictors easily obtained at presentation predict resource utilization in unstable angina. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines "Inadvertent" thrombolytic administration in patients without myocardial infarction: clinical features and outcome Evolution of the management of acute myocardial infarction: a 20th century saga. wd:Q22242895 Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Early management of acute myocardial infarction: thrombolysis, angioplasty, and adjunctive therapies Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina Improving outcomes in acute coronary syndromes--the FRISC II trial Long-term low-molecular-weight heparin (Fragmin) and/or early revascularization during instability in coronary artery disease (the FRISC II Study). ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab Contemporary approach to management of unstable angina Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. Evaluation of a paired creatine kinase test for the diagnosis of acute myocardial infarction in patients with a non-diagnostic electrocardiogram Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris Early angiography in patients with chronic kidney disease: a collaborative systematic review Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost What role for catheter laboratories in unstable angina? Patient risk or physician practice: what factors drive resource use in unstable angina? Evaluation of chest pain in the emergency department Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction: MITI Investigators. Myocardial Infarction Triage and Intervention Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. Outcomes in patients with non-ST-elevation acute coronary syndrome randomly assigned to invasive versus conservative treatment strategies: a meta-analysis Avoidance of routine revascularization in the management of patients with non-ST-segment elevation acute coronary syndromes An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction Long-Term clinical outcomes according to initial management and thrombolysis in myocardial infarction risk score in patients with acute non-ST-segment elevation myocardial infarction Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software